Description
Obagi-C Rx System C-Exfoliating Day Lotion -- 2 oz. With Obagi-C Rx, you're on your way to healthier, refreshed, revitalized skin from cell to surface. The Obagi-C Rx System offers the benefits of both prescription-strength 4% hydroquinone and potent Vitamin C to correct signs of skin damage and help restore and maintain younger-looking skin. Obagi-C Rx System products are ideal if you have minimal fine lines, minimal unevenness of skin tone, mild hyperpigmentation and minimal age spots, intolerance to, or are not ready for, more aggressive anti-aging regimens and dry, normal, oily or even sensitive skin. Obagi-C Rx System C-Exfoliating Day Lotion exfoliates the outermost layer of the skin to enhance penetration of active ingredients. Antioxidant activity as a result of Obagi-C Rx System C-Exfoliating Day Lotion neutralizes free radicals and prevents future damage. Exfoliates the outermost layer of the skin Enhances penetration of active ingredients Neutralizes free radicals Especially Suited For: Normal to dry skinEssential Elements: Obagi-C Rx System C-Exfoliating Day Lotion comes in a 2-oz. bottle.For Best Effect: Apply to the face and neck in the morning after applying Obagi-C Rx System C-Clarifying Serum. Massage in gently.
Ingredients
Active Ingredients: Octinoxate 7.5%, Octisalate 5%, Oxybenzone 4% Inactive Ingredients: Water (aqua), Caprylic/Capric Triglyceride, Hydorxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Squalane, Polysorbate 60, Sodium Hydroxide, Glyceryl Stearate, PEG-100 Stearate, Ceteryl Alcohol, Ceteareth-20, Glycolic Acid, Glycerin, Arginine, PEG-8 Dimethicone, PEG/PPG-10/2 Ricinoleate, Dimethicone, Steareth-2, Tetrasodium EDTA, Bisabolol, Sodium Hyaluronate (Hyaluronic Acid), Ascorbyl Glucoside (Vitamin C), Tocopheryl Acetate (Vitamin E), Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben, Isobutylparaben, Fragrance.
Find the best deals
- $30.00 Amazon http://astore.amazon.com
Sending...
This product was successfully sent to your friend!
There was an error, please try later...
Facebook
Twitter
Ask a question or leave a comment
0 comments